Value Bridge — GRITMAN MEDICAL CENTER
Current $-6M → Target $-4M (+$2.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-5.9M
Current EBITDA
$-3.9M
Target EBITDA
+$2.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.5M
Payer Mix Optimization
$1.1M
Cost to Collect Reduction
$0.4M
Clean Claim Improvement
$0.3M
Volume & Rate Growth
$1.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-6M to $-4M. The highest-impact lever is Volume & Rate Growth at $0.7M probability-weighted.
IC talking point: "We see $2M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $22M in equity value creation."